LAVELLE ERIN (Chief Operating Officer) received a stock award from ALDER BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/24/2019ACC: 0001209191-19-053922
Officer· Chief Operating Officer
Since Feb 2019
-454.41K
Net shares
Net seller
$289.7K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
11.68K acquired · 466.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.68K
Price / share
—
Trade value
—
% of position
265.1%
10/22/2019
4.41K→16.09K
Common Stock
Direct
Shares
−16.09K
Price / share
$18.00
Trade value
$289.66K
% of position
New position
10/22/2019
16.09K→0.00
Total
Net shares
−4.41K
Net value
-$289.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/22/2019 | A · Award | +11.68K | — | — | 265.1% | 4.41K | 16.09K |
| Common Stock Direct | 10/22/2019 | U · U | −16.09K | $18.00 | $289.66K | New position | 16.09K | 0.00 |
| Total | −4.41K | -$289.66K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
300K shares
Shares
−300K
Strike price
14.55
Held after
0.00
Exercisable
—
10/22/2019
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
150K shares
Shares
−150K
Strike price
14.00
Held after
0.00
Exercisable
—
10/22/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock300K shares | 10/22/2019 | D · Disposition | −300K | 14.55 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock150K shares | 10/22/2019 | D · Disposition | −150K | 14.00 | — | 0.00 |